262 related articles for article (PubMed ID: 35197539)
41. Expression of PD-1/PD-L1 axis in mediastinal lymph nodes and lung tissue of human and experimental lung fibrosis indicates a potential therapeutic target for idiopathic pulmonary fibrosis.
Karampitsakos T; Galaris A; Chrysikos S; Papaioannou O; Vamvakaris I; Barbayianni I; Kanellopoulou P; Grammenoudi S; Anagnostopoulos N; Stratakos G; Katsaras M; Sampsonas F; Dimakou K; Manali ED; Papiris S; Tourki B; Juan-Guardela BM; Bakakos P; Bouros D; Herazo-Maya JD; Aidinis V; Tzouvelekis A
Respir Res; 2023 Nov; 24(1):279. PubMed ID: 37964265
[TBL] [Abstract][Full Text] [Related]
42. Arsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo.
Luo F; Zhuang Y; Sides MD; Sanchez CG; Shan B; White ES; Lasky JA
Respir Res; 2014 Apr; 15(1):51. PubMed ID: 24762191
[TBL] [Abstract][Full Text] [Related]
43. Ubiquitin carboxyl-terminal hydrolase-L5 promotes TGFβ-1 signaling by de-ubiquitinating and stabilizing Smad2/Smad3 in pulmonary fibrosis.
Nan L; Jacko AM; Tan J; Wang D; Zhao J; Kass DJ; Ma H; Zhao Y
Sci Rep; 2016 Sep; 6():33116. PubMed ID: 27604640
[TBL] [Abstract][Full Text] [Related]
44. Tacrolimus induces fibroblast-to-myofibroblast transition via a TGF-β-dependent mechanism to contribute to renal fibrosis.
Ume AC; Wenegieme TY; Shelby JN; Paul-Onyia CDB; Waite AMJ; Kamau JK; Adams DN; Susuki K; Bennett ES; Ren H; Williams CR
Am J Physiol Renal Physiol; 2023 May; 324(5):F433-F445. PubMed ID: 36927118
[TBL] [Abstract][Full Text] [Related]
45. Local administration of liposomal-based Srpx2 gene therapy reverses pulmonary fibrosis by blockading fibroblast-to-myofibroblast transition.
Wang Q; Liu J; Hu Y; Pan T; Xu Y; Yu J; Xiong W; Zhou Q; Wang Y
Theranostics; 2021; 11(14):7110-7125. PubMed ID: 34093874
[TBL] [Abstract][Full Text] [Related]
46. TGF-β1-induced miR-424 promotes pulmonary myofibroblast differentiation by targeting Slit2 protein expression.
Huang Y; Xie Y; Abel PW; Wei P; Plowman J; Toews ML; Strah H; Siddique A; Bailey KL; Tu Y
Biochem Pharmacol; 2020 Oct; 180():114172. PubMed ID: 32712053
[TBL] [Abstract][Full Text] [Related]
47. Dual inhibition of α
Decaris ML; Schaub JR; Chen C; Cha J; Lee GG; Rexhepaj M; Ho SS; Rao V; Marlow MM; Kotak P; Budi EH; Hooi L; Wu J; Fridlib M; Martin SP; Huang S; Chen M; Muñoz M; Hom TF; Wolters PJ; Desai TJ; Rock F; Leftheris K; Morgans DJ; Lepist EI; Andre P; Lefebvre EA; Turner SM
Respir Res; 2021 Oct; 22(1):265. PubMed ID: 34666752
[TBL] [Abstract][Full Text] [Related]
48. Lysine-specific demethylase-1 regulates fibroblast activation in pulmonary fibrosis via TGF-β1/Smad3 pathway.
Pan X; Li J; Tu X; Wu C; Liu H; Luo Y; Dong X; Li X; Pan LL; Sun J
Pharmacol Res; 2020 Feb; 152():104592. PubMed ID: 31830521
[TBL] [Abstract][Full Text] [Related]
49. TNF-α-induced NF-κB activation promotes myofibroblast differentiation of LR-MSCs and exacerbates bleomycin-induced pulmonary fibrosis.
Hou J; Ma T; Cao H; Chen Y; Wang C; Chen X; Xiang Z; Han X
J Cell Physiol; 2018 Mar; 233(3):2409-2419. PubMed ID: 28731277
[TBL] [Abstract][Full Text] [Related]
50. HSP27 regulates TGF-β mediated lung fibroblast differentiation through the Smad3 and ERK pathways.
Wang G; Jiao H; Zheng JN; Sun X
Int J Mol Med; 2017 Jan; 39(1):183-190. PubMed ID: 27909724
[TBL] [Abstract][Full Text] [Related]
51. Role of fibroblast growth factor 23 and klotho cross talk in idiopathic pulmonary fibrosis.
Barnes JW; Duncan D; Helton S; Hutcheson S; Kurundkar D; Logsdon NJ; Locy M; Garth J; Denson R; Farver C; Vo HT; King G; Kentrup D; Faul C; Kulkarni T; De Andrade JA; Yu Z; Matalon S; Thannickal VJ; Krick S
Am J Physiol Lung Cell Mol Physiol; 2019 Jul; 317(1):L141-L154. PubMed ID: 31042083
[TBL] [Abstract][Full Text] [Related]
52. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways.
Li J; Feng M; Sun R; Li Z; Hu L; Peng G; Xu X; Wang W; Cui F; Yue W; He J; Liu J
Toxicol Lett; 2020 Mar; 321():103-113. PubMed ID: 31706003
[TBL] [Abstract][Full Text] [Related]
53. TGF-beta1 targets the GSK-3beta/beta-catenin pathway via ERK activation in the transition of human lung fibroblasts into myofibroblasts.
Caraci F; Gili E; Calafiore M; Failla M; La Rosa C; Crimi N; Sortino MA; Nicoletti F; Copani A; Vancheri C
Pharmacol Res; 2008 Apr; 57(4):274-82. PubMed ID: 18346908
[TBL] [Abstract][Full Text] [Related]
54. GRK2 promotes activation of lung fibroblast cells and contributes to pathogenesis of pulmonary fibrosis through increasing Smad3 expression.
Li Y; Sun Y; Wu N; Ma H
Am J Physiol Cell Physiol; 2022 Jan; 322(1):C63-C72. PubMed ID: 34852209
[TBL] [Abstract][Full Text] [Related]
55. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
[TBL] [Abstract][Full Text] [Related]
56. Cigarette smoking aggravates bleomycin-induced experimental pulmonary fibrosis.
Zhou LL; Wang M; Liu F; Lu YZ; Song LJ; Xiong L; Xiang F; He XL; Shuai SY; Xin JB; Ye H; Yu F; Ma WL
Toxicol Lett; 2019 Mar; 303():1-8. PubMed ID: 30572104
[TBL] [Abstract][Full Text] [Related]
57. Human antigen R promotes lung fibroblast differentiation to myofibroblasts and increases extracellular matrix production.
Al-Habeeb F; Aloufi N; Traboulsi H; Liu X; Nair P; Haston C; Azuelos I; Huang SK; White ES; Gallouzi IE; Di Marco S; Eidelman DH; Baglole CJ
J Cell Physiol; 2021 Oct; 236(10):6836-6851. PubMed ID: 33855709
[TBL] [Abstract][Full Text] [Related]
58. Calycosin attenuates pulmonary fibrosis by the epithelial-mesenchymal transition repression upon inhibiting the AKT/GSK3β/β-catenin signaling pathway.
Liu X; Shao Y; Zhang X; Ji X; Xie M; Liu H
Acta Histochem; 2021 Jul; 123(5):151746. PubMed ID: 34217047
[TBL] [Abstract][Full Text] [Related]
59. β-catenin and Smad3 regulate the activity and stability of myocardin-related transcription factor during epithelial-myofibroblast transition.
Charbonney E; Speight P; Masszi A; Nakano H; Kapus A
Mol Biol Cell; 2011 Dec; 22(23):4472-85. PubMed ID: 21965288
[TBL] [Abstract][Full Text] [Related]
60. Anti-fibrotic effect of iguratimod on pulmonary fibrosis by inhibiting the fibroblast-to-myofibroblast transition.
Lin H; Wu C; Zhu F; Zhang G; Xie Y; Cui Y; Dong G; Zhang X
Adv Med Sci; 2020 Sep; 65(2):338-347. PubMed ID: 32590154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
